Clinical Trials in Wollstonecraft, New South Wales
12 recruiting
Showing 1–12 of 12 trials
Recruiting
Phase 2
Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma
Melanoma Metastatic
Melanoma Institute Australia129 enrolled5 locationsNCT06767306
Recruiting
Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid TumorsHematologic Malignancies
Merck Sharp & Dohme LLC3,500 enrolled777 locationsNCT03486873
Recruiting
Phase 2
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Malignant Melanoma
Merck Sharp & Dohme LLC160 enrolled38 locationsNCT06961006
Recruiting
Phase 1Phase 2
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Advanced Solid Tumors
ModernaTX, Inc.361 enrolled28 locationsNCT05533697
Recruiting
Phase 2Phase 3
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Metastatic Uveal Melanoma
Replimune, Inc.280 enrolled33 locationsNCT06581406
Recruiting
Phase 1Phase 2
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Advanced Solid Tumor
BioNTech SE980 enrolled53 locationsNCT07070232
Recruiting
Phase 3
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Advanced Melanoma
Immunocore Ltd540 enrolled82 locationsNCT05549297
Recruiting
Phase 2
Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)
Cutaneous MelanomaMucosal Melanoma
Melanoma Institute Australia494 enrolled1 locationNCT06999980
Recruiting
Not Applicable
The Multicentre Selective Lymphadenectomy Trial - 3
Cutaneous Melanoma, Stage III
Melanoma Institute Australia1,500 enrolled6 locationsNCT07049276
Recruiting
Phase 2
Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma
Merkel Cell Carcinoma
Melanoma Institute Australia20 enrolled1 locationNCT06151236
Recruiting
Phase 2
Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
Melanoma Institute Australia218 enrolled9 locationsNCT03340129
Recruiting
Phase 2
Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma
Cutaneous Squamous Cell Carcinoma
Melanoma Institute Australia20 enrolled1 locationNCT06288191